Related Experiment Video
Updated: Aug 11, 2026

The WATCHMAN Left Atrial Appendage Closure Device for Atrial Fibrillation
Published on: February 28, 2012
Warfarin sensitivity after mechanical heart valve replacement
1Department of Pharmacy, Allegheny University Hospitals, Allegheny General, Pittsburgh, Pennsylvania, USA.
Insights
Patients on warfarin post-mechanical heart valve replacement show increased drug sensitivity. Early reduced warfarin dosages may be necessary to manage international normalized ratio (INR) levels safely in these individuals.
Area of Science:
- Cardiology
- Pharmacology
- Medical Research
Background:
- Warfarin is a common anticoagulant used to prevent thrombosis.
- Mechanical heart valve replacement necessitates long-term anticoagulation therapy.
- Understanding warfarin sensitivity is crucial for safe and effective patient management.
Purpose of the Study:
- To evaluate warfarin sensitivity in patients following mechanical heart valve replacement.
- To compare international normalized ratio (INR) levels in this group versus patients on anticoagulation for other indications.
Main Methods:
- Retrospective chart review of 60 patients post-mechanical heart valve replacement.
- Comparison with a control group of 100 patients receiving anticoagulation for atrial fibrillation, pulmonary embolism, or deep vein thrombosis.
- Analysis of international normalized ratio (INR) on day 3 of warfarin therapy.
Main Results:
- Patients post-mechanical heart valve replacement had a significantly higher mean INR (4.1+/-3.9) on day 3 compared to controls (1.9+/-0.7).
- A wide range of INR values (1.1-17.1) was observed in the mechanical heart valve replacement group.
- The difference in INR between the groups was statistically significant (p<0.05).
Conclusions:
- Patients receiving warfarin after mechanical heart valve replacement exhibit heightened sensitivity to the anticoagulant.
- Lower initial warfarin dosages might be required during the first three days post-valve replacement.
- Further research into optimized dosing strategies for this patient population is warranted.
Abstract:
We performed a retrospective chart review of 60 patients after mechanical heart valve replacement to assess warfarin sensitivity. The overall international normalized ratio (INR) on day 3 of therapy was 4.1+/-3.9 (range 1.1-17.1). In a control group of 100 patients who received anticoagulation for atrial fibrillation, pulmonary embolism, and deep vein thrombosis, the overall mean INR at day 3 was 1.9+/-0.7 (range 1.0-4.9). The difference between groups was statistically significant (p<0.05). We conclude that patients receiving warfarin after mechanical heart valve replacement are more sensitive to the drug than those receiving it for other indications, and reduced dosages may be necessary during the first 3 days after valve replacement.
Related Concept Videos
Anticoagulant Drugs: Low-Molecular-Weight Heparins
Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
Mitral Stenosis III: Medical Management
Mitral Stenosis IV: Nursing Management
Endocarditis III: Medical Management
Venous Thrombosis III: Interprofessional Care

